CJC-1295 with Ipamorelin 10MG – Professional Research Peptide Blend

Product Description

CJC-1295 with Ipamorelin 10 mg – Synergistic GHRH and GHRP Blend for GH Release and Recovery Research

Composition:
5 mg CJC-1295 (no DAC)
5 mg Ipamorelin
Total: 10 mg lyophilized peptide blend
Category: Peptide Blend
Form: Vial with freeze-dried powder
Administration: Subcutaneous research application (requires reconstitution)

What is CJC-1295 with Ipamorelin?

CJC-1295 with Ipamorelin is a dual-action peptide blend that combines two well-researched growth hormone stimulators.
CJC-1295 acts as a GHRH analog, associated with natural GH release via GHRH receptor pathways, while
Ipamorelin is a highly selective GHRP peptide that binds to ghrelin receptors to amplify GH pulses without affecting cortisol or prolactin levels in research models.

Each vial contains 5 mg CJC-1295 and 5 mg Ipamorelin, delivering a balanced and synergistic effect suitable for studies focused on
GH secretion, recovery mechanisms, and metabolic performance.

➡️ Ideal for research on regenerative biology, recovery performance, and endocrine signaling.

Key Research Findings

• Dual Mechanism GH Release: CJC-1295 binds to GHRH pathways, while Ipamorelin interacts with ghrelin receptors for amplified GH pulses.
• Balanced Synergy: The 5 mg + 5 mg formulation supports stable GH release and predictable pharmacodynamics.
• Recovery and Repair: Demonstrated in preclinical studies to studied for potential influence on tissue regeneration and protein synthesis.
• Lean Mass Support: Investigated for its effects on maintaining lean tissue and influencing metabolic efficiency.
• Highly Selective Profile: Ipamorelin delivers targeted GH release with minimal off-target hormonal interactions.

Dosage and Application

Reconstitute with bacteriostatic water before use.

Commonly referenced research protocols: 200–500 mcg of the combined blend per application, administered subcutaneously
1–3 times daily depending on study design.

Store the reconstituted solution in a refrigerator and use within 30 days.

Storage Instructions

• Store at 2–8 °C (36–46 °F)
• Protect from light and moisture
• Do not freeze
• Avoid temperature fluctuations

Why Choose CJC-1295 with Ipamorelin?

The 5 mg + 5 mg blend provides a precisely balanced combination of GHRH and GHRP activity.
Its complementary dual mechanism, consistent GH pulse profile, and strong research foundation make it a preferred choice for studies exploring
growth hormone dynamics, recovery processes, and regenerative physiology.

Explore the potential of CJC-1295 with Ipamorelin 10 mg for advanced research into GH secretion, tissue repair, and metabolic optimization.

Technical Specifications

• Product Code: CJC-IPA-10MG
• Purity: ≥ 98% (HPLC)
• Form: Lyophilized powder
• Storage: −20 °C (before reconstitution), 2–8 °C (after reconstitution)
• Stability: 2 years lyophilized, 30 days reconstituted when properly stored

Quality Assurance

Each batch of CJC-1295 with Ipamorelin undergoes comprehensive laboratory analysis including:

• HPLC testing for purity verification
• Mass spectrometry for molecular identity confirmation
• Endotoxin and sterility testing for research reliability

References and Further Reading

For detailed study data, consult peer-reviewed publications on GHRH and GHRP synergy available through PubMed and other scientific databases.
All peptides are produced according to current laboratory research standards and specifications.